Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$101M in Q4 2020 → $60.4M now. Hover for any quarter.
As reported for the quarter ended September 30, 2021. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| IN Impel Neuropharma, Inc. | 62.1% | Unchanged | 3,077,198 | $37.5M |
| Opendoor Technologies, Inc. | 37.9% | Trimmed 67% | 1,116,185 | $22.9M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2021 · filed October 27, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Opendoor Technologies, Inc. | Trimmed | −2,232,370 | −$45.8M | 37.9% |
quarter ended June 30, 2021 · filed August 10, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IN Impel Neuropharma, Inc. | New | +3,077,198 | +$27.2M | 31.4% |
| Opendoor Technologies Inc. | Trimmed | −1,116,185 | −$19.8M | 68.6% |
quarter ended March 31, 2021 · filed April 21, 2021
No position changes this quarter.
Loading...
